<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta content="width=device-width, initial-scale=1.0" name="viewport">
    <meta content="ie=edge" http-equiv="X-UA-Compatible">
    <title>Tech4Dev | Gloepid</title>
    <link href="../../assets/css/gloepid.css" rel="stylesheet">
    <link href="../../assets/images/icon.png" rel="shortcut icon" type="image/x-icon">
</head>
<body>
<header>
    @@include('./includes/nav.html',{"active": "programs"})
    <div>
        <img alt="Hero" class="hero-image" src="../../assets/images/glopid-banner.png">
        <div class="hero-text">
            GLOEPID
        </div>
    </div>
</header>
<main>
    <div class="page-links">
        <a class="page-link page-link--active" href="./index.html">
            WHAT WE DO
        </a>
        <a class="page-link" href="./get-involved.html">
            GET INVOLVED
        </a>
    </div>
    <div class="grid">
        <div class="share-links">
            <a class="share-link" href="http://www.twiter.com/gloepid" target="_blank">
                <svg aria-role="img" class="share-link__icon" fill="currentColor"
                     viewBox="0 0 64 64" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
                    <path d="M60.448 15.109a24.276 24.276 0 0 1-3.288.968.5.5 0 0 1-.451-.853 15.146 15.146 0 0 0 3.119-4.263.5.5 0 0 0-.677-.662 18.6 18.6 0 0 1-6.527 2.071 12.92 12.92 0 0 0-9-3.75A12.363 12.363 0 0 0 31.25 20.994a12.727 12.727 0 0 0 .281 2.719c-9.048-.274-19.61-4.647-25.781-12.249a.5.5 0 0 0-.83.073 12.475 12.475 0 0 0 2.956 14.79.5.5 0 0 1-.344.887 7.749 7.749 0 0 1-3.1-.8.5.5 0 0 0-.725.477 11.653 11.653 0 0 0 7.979 10.567.5.5 0 0 1-.09.964 12.567 12.567 0 0 1-2.834 0 .506.506 0 0 0-.536.635c.849 3.282 5.092 7.125 9.839 7.652a.5.5 0 0 1 .267.87 20.943 20.943 0 0 1-14 4.577.5.5 0 0 0-.255.942 37.29 37.29 0 0 0 17.33 4.266 34.5 34.5 0 0 0 34.687-36.182v-.469a21.11 21.11 0 0 0 4.934-4.839.5.5 0 0 0-.58-.765z"
                          data-name="layer1" stroke-linecap="round" stroke-linejoin="round" stroke-miterlimit="10"
                          stroke-width="2"></path>
                </svg>
            </a>
            <a class="share-link" href="http://www.instagram.com/gloepid">
                <svg aria-describedby="desc" aria-labelledby="title" class="share-link__icon"
                     role="img" viewBox="0 0 64 64" xmlns="http://www.w3.org/2000/svg"
                     xmlns:xlink="http://www.w3.org/1999/xlink">
                    <path d="M44.122 2H19.87A17.875 17.875 0 0 0 2 19.835v24.2a17.875 17.875 0 0 0 17.87 17.834h24.252A17.875 17.875 0 0 0 62 44.034v-24.2A17.875 17.875 0 0 0 44.122 2zM55.96 44.034a11.825 11.825 0 0 1-11.838 11.812H19.87A11.825 11.825 0 0 1 8.032 44.034v-24.2A11.825 11.825 0 0 1 19.87 8.022h24.252A11.825 11.825 0 0 1 55.96 19.835zm0 0"
                          data-name="layer2"
                          fill="#FF576B" stroke="white" stroke-linecap="round" stroke-linejoin="round"
                          stroke-miterlimit="10" stroke-width="2"></path>
                    <path d="M32 16.45a15.484 15.484 0 1 0 15.514 15.484A15.519 15.519 0 0 0 32 16.45zm0 24.95a9.461 9.461 0 1 1 9.482-9.461A9.472 9.472 0 0 1 32 41.4zm19.263-24.834a3.719 3.719 0 1 1-3.719-3.711 3.714 3.714 0 0 1 3.719 3.711zm0 0"
                          data-name="layer1"
                          fill="#FF576B" stroke="white" stroke-linecap="round" stroke-linejoin="round"
                          stroke-miterlimit="10" stroke-width="2"></path>
                </svg>
            </a>
        </div>
        <div class="benefits">
            <h3 class="benefits-header">
                BENEFITS
            </h3>
            <span class=benefits-split-line></span>
            <p class="benefits-text">
                Providing NCDC with the much-needed ability to carry out comprehensive contact tracing of individuals at
                population scale
            </p>
            <span class=benefits-split-line></span>
            <p class="benefits-text">
                Easing the burden of the NCDC contact center and
                strengthening NCDC's communication capacity by providing other communication channels to carry
                out self-risk assessments and report symptoms
            </p>
            <span class=benefits-split-line></span>
            <a class="benefits-link" href="https://gloepid.org/">
                Visit Website
            </a>
        </div>
        <div>
            <p class="body-text">
                In the face of the Coronavirus global pandemic, we have all lost in some way, our work has been
                affected, and our lives are changing rapidly by the turn of events. How do we fight against a virus that
                grows exponentially, threatening to cripple not just our health and medical institutions but our
                economy?
            </p>
            <p class="body-text">
                The most effective defense is to stop the spread of this virus by accurately tracking and mapping all
                COVID -19 cases, and this is where Glo Epid comes in.
            </p>
            <p class="body-text">
                GloEpid is a Not for profit initiative built by volunteer efforts to help combat COVID-19 effectively by
                strengthening the ability of the Nigeria Centre for Disease Control (NCDC) to trace contacts of all
                confirmed cases down to he areas or people they might have come in contact with, as well as allow people
                to self-assess if they have symptoms of the virus.
            </p>
            <p class="body-text">
                Gloepid is a two-pronged tracking and surveillance technology solution focused on contact tracing, self
                assessment, and reporting to identify quickly track travel, and contact information, to be able to
                contain the spread of COVID-19.
            </p>
        </div>
    </div>
    @@include('./includes/footer.html')
    <script src="../../assets/js/nav.js"></script>
</main>
</body>
</html>